Back
Lyell Immunopharma, Inc. Stock Predictions
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
28
LYEL
Lyell Immunopharma, Inc.
Last Price:
$23.86
Seasonality Move:
-14.02%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available atLyell Immunopharma, Inc. Stock Forecast
-
Over the next 52 weeks, Lyell Immunopharma, Inc. has on average historically fallen by 14.7% based on the past 4 years of stock performance.
-
Lyell Immunopharma, Inc. has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
-
Is Lyell Immunopharma, Inc. Stock Undervalued?The current Lyell Immunopharma, Inc. [LYEL] share price is $23.76. The Score for LYEL is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
LYEL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Lyell Immunopharma, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Lyell Immunopharma, Inc. has on average historically fallen by 14.7% based on the past 4 years of stock performance.
Lyell Immunopharma, Inc. Stock Rating
Sell
28
Lyell Immunopharma, Inc. (LYEL)
is a Sell
Is Lyell Immunopharma, Inc. overpriced?
-
Lyell Immunopharma, Inc. has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
Lyell Immunopharma, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
lyell.com
52-Week Data
52-Week High:
45.00
52-Week Low:
7.65
Prediction Charts
Market Cap:
351.8M
Price in USD:
23.76
Volume:
152.2K
Beta:
-0.14
Technical Analysis
SMA50:
25.30
SMA100:
20.06
SMA200:
14.87
52-Wk Change:
112.56%
Stock Predictions
-
Is Lyell Immunopharma, Inc. stock public?Yes, Lyell Immunopharma, Inc. is a publicly traded company.
-
What is the Lyell Immunopharma, Inc. stock quote today?The Lyell Immunopharma, Inc. stock price is 23.76 USD today.
-
How to buy Lyell Immunopharma, Inc. stock online?You can buy Lyell Immunopharma, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-26 | 38.63 | 35.09 | 38.63 | 34.52 |
| Dec-29 | 35.03 | 36.05 | 37.00 | 34.42 |
| Dec-30 | 36.01 | 31.59 | 36.01 | 30.76 |
| Dec-31 | 31.28 | 30.78 | 32.28 | 30.01 |
| Jan-5 | 28.99 | 28.01 | 29.21 | 25.81 |
| Jan-6 | 27.79 | 25.73 | 29.10 | 25.70 |
| Jan-7 | 25.91 | 25.05 | 26.49 | 24.69 |
| Jan-8 | 25.20 | 24.30 | 25.34 | 24.30 |
| Jan-9 | 24.34 | 24.55 | 25.75 | 24.34 |
| Jan-12 | 24.59 | 23.77 | 24.85 | 22.75 |
| Jan-13 | 23.88 | 23.71 | 25.12 | 23.05 |
| Jan-14 | 23.64 | 23.46 | 24.38 | 23.38 |
| Jan-15 | 23.54 | 22.93 | 23.99 | 22.38 |
| Jan-16 | 22.90 | 23.76 | 24.96 | 22.86 |
Lyell Immunopharma, Inc. Earnings
Lyell Immunopharma, Inc. Earnings Report: Per Share Lyell Immunopharma, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Lyell Immunopharma, Inc. Forecast Revenue Growth
Lyell Immunopharma, Inc. Stock Analysis: Historical quarterly revenues per share for Lyell Immunopharma, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.96 per share, and a decrease next year of $0.00 per share.
* Lyell Immunopharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.